Akshara’s dream to pursue as a pharmacist & follow her hobby to dance and mountain climbing in her second phase of life.
~The patient was suffering from a ventricular septal defect, since childhood, and lack of awareness and timely treatment led to Eisenmenger’s syndrome
~Combined Heart and Lung Transplant was the only treatment option available for the youngster
MUMBAI, 24 AUGUST, 2019 (GPN): A 24 year old Mumbai girl who was suffering from a rare and complex congenital heart disease underwent a combined heart and lung transplant at Global Hospital, Mumbai. Akshara a resident of Panvel, Mumbai suffered from ventricular septal defect since childhood and this defect over the years led to Eisenmenger’s syndrome. Although she was managed medically for a very long time, her condition worsened off late, and she had to be put on home-based oxygen therapy. The 24-year-old underwent a combined heart and lung transplant in the month of June 2019 and is recovering well.
The burden of patients with inoperable adult congenital heart disease and secondary pulmonary hypertension in this country is overwhelming. These individuals have a condition called Eisenmengers syndrome. Many of them continue to turn deeply blue over time and develop secondary complications like cerebral strokes, severe right heart failure, infective endocarditis and die painful deaths after suffering immeasurably.
Dr Sandeep Attawar, Director and Chair of the Heart & Lung Program, Gleneagles Global Hospitals said,“The individuals who have Eisenmengers syndrome could have undergone corrective heart surgery in their infancy or childhood that would have prevented this fate. However, it is only of recent that these facilities have been more common place in this country. So, these individuals that missed the bus, now are condemned to a pathetic existence unless an option such as the replacement of these seriously damaged organs is considered or feasible.”
“However, for the replacement of the seriously damaged organs, there has to be an increase in deceased organ donation,” stated Dr Sandeep.
He also mentioned that there is an uptick in awareness on organ donation and a ray of hope for individuals with this advanced and medically untreatable heart disease.
“The final solution for Eisenmengers syndrome is a heart and double lung transplantation. Akshara is one such young girl who had ventricular septal defect that wasn’t operated upon in her childhood. Heart-lung transplantation is the simultaneous surgical replacement of the heart and lungs in patients having end-stage cardiac and pulmonary disease. It is a viable treatment option,” mentioned Dr Attawar.
Patients who are chosen for the heart and lung transplantation are selected carefully after a series of coordinated and properly sequenced steps. As per The International Society for Heart and Lung Transplantation, the indications for heart and lung transplant are congenital heart disease with Eisenmenger syndrome followed by idiopathic primary pulmonary hypertension with terminal right heart failure and cystic fibrosis with severe right heart dysfunction.
Akshara’s transplant lasted for 6 –7 hours. Post-surgery she was rehabilitated and was subsequently discharged in mid-July. She has been regularly following up with the clinical team and is recuperating well. Her follow up lung biopsies and levels of immunosuppressive medications are being monitored closely and treated under close medical supervision.
Patient Akshara Aher says, ” I am thankful to Global Hospital transplant team who have helped me to pursue my dream as a pharmacist & follow her hobby to dance and mountain climbing in her second phase of life.
Dr Vivek Talaulikar, Chief Executive Officer, Global Hospital said, “I would like to thank our doctor teams for their tremendous efforts that they have put in to give Akshara a new lease of life. Till date, Global Hospital, Mumbai, has successfully carried out three bilateral lung transplants, and 1 combined heart and bilateral lung transplant. Our program will offer a safe and caring atmosphere for all patients like all our other organ transplant programs running for decades across India.”
“I would specially thank the donor family who have taken up a brave cause of donating the organs of their loved ones. Today as you see, organ donation has given a new life for this youngster. I would appeal to the communities via the media to come forward and pledge for organ donation,” added Dr Vivek. ENDS
About Global Hospitals, Mumbai
Global Hospitals located at Lower Parel, Mumbai is the latest addition to the geographical footprint of Gleneagles Global Hospitals India. The 450-bed facility comprises of 17-stories, housing state-of-the-art infrastructure and advanced medical care facilities. The hospital offers end-to-end clinical, surgical and diagnostic services. The Hospital offers advanced Endoscopic procedures, Hepatobiliary and Liver Surgeries, Surgical and Medical Gastroenterology, Bariatric Surgery and Transplants. The hospital is a centre of excellence for Orthopaedics, Joint Replacement, Knee Replacement, Hip Replacement surgery. The hospital has round-the-clock services for Emergencies, Critical Care and Trauma.
Gleneagles Global Hospitals has multi-super speciality hospitals in Bengaluru, Hyderabad, Chennai and Mumbai. The brand is the most preferred hospital group for multi-organ transplants in Asia region. The parent entity of Gleneagles Global Hospitals is IHH Healthcare, a leading premium integrated healthcare provider with a network of 84 hospitals and more than 16,000 licensed beds. It is one of the largest healthcare groups in the world by market capitalisation and is listed in the Main Market of Bursa Malaysia and Main Board of SGX-ST. IHH is a leading player in the home markets of Malaysia, Singapore, Turkey and India, and in their key growth markets of China and Hong Kong.